Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine in bronchiectasis
ACTRN12615001344583Phase 2Completed
- Sponsor
- Dr Conroy Wong
- Start
- Feb 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of clonidine in bronchiectasis (2 arms), sponsored by Dr Conroy Wong. Primary endpoint: Change in sputum IL-8 concentration. Started Feb 2016; status: completed.
02
Drugs
clonidine
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on ACTRN12615001344583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615001344583.